B. Favreau

Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.

M. P. Kane, L. Briceland, R. Garris, 1990, American journal of hospital pharmacy.

A new method for the large scale preparation of antitoxic antibodies exhibiting high specific protective activities

B. Bizzini, D. Giurgiu, B. Favreau, 1983, Experientia.

Quantitative and Qualitative Analysis of Medication Errors: The New York Experience

Ellen Flink, Angelo Ruperto, Ruth Leslie, 2005 .

Table 1, Medication errors resulting in death, near death experience, or permanent patient harm—New York Patient Occurrence Reporting and Tracking System (NYPORTS)

E. Duthie, E. Flink, B. Favreau, 2005 .